Summary of Significant Accounting Policies - Summary of Revenue by Category (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Disaggregation Of Revenue [Line Items]
Revenue		$ 66,940	$ 56,891	$ 207,112	$ 171,334
PGS
Disaggregation Of Revenue [Line Items]
Revenue		42,599	38,367	131,616	130,705
PGS | Point in Time
Disaggregation Of Revenue [Line Items]
Revenue		37,499	35,090	117,300	121,516
PGS | Over Time
Disaggregation Of Revenue [Line Items]
Revenue		5,100	3,277	14,316	9,189
Telehealth
Disaggregation Of Revenue [Line Items]
Revenue		11,043	7,673	34,595	7,673
Telehealth | Point in Time
Disaggregation Of Revenue [Line Items]
Revenue		2,451	1,527	7,471	1,527
Telehealth | Over Time
Disaggregation Of Revenue [Line Items]
Revenue		8,592	6,146	27,124	6,146
Consumer services
Disaggregation Of Revenue [Line Items]
Revenue		53,642	46,040	166,211	138,378
Consumer services | Point in Time
Disaggregation Of Revenue [Line Items]
Revenue		46,091	41,236	144,424	127,662
Consumer services | Over Time
Disaggregation Of Revenue [Line Items]
Revenue		7,551	4,804	21,787	10,716
Research Services
Disaggregation Of Revenue [Line Items]
Revenue		13,298	10,851	40,901	32,956
Research Services | Point in Time
Disaggregation Of Revenue [Line Items]
Revenue		0	0	0	0
Research Services | Over Time
Disaggregation Of Revenue [Line Items]
Revenue		13,298	10,851	40,901	32,956
Service
Disaggregation Of Revenue [Line Items]
Revenue	[1]	66,940	56,891	207,112	171,334
Service | Point in Time
Disaggregation Of Revenue [Line Items]
Revenue	[1]	46,091	41,236	144,424	127,662
Service | Over Time
Disaggregation Of Revenue [Line Items]
Revenue	[1]	$ 20,849	$ 15,655	$ 62,688	$ 43,672
Product Concentration Risk [Member] | Revenue Benchmark [Member] | PGS
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		64.00%	67.00%	63.00%	76.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | PGS | Point in Time
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		56.00%	62.00%	57.00%	71.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | PGS | Over Time
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		7.00%	6.00%	7.00%	5.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Telehealth
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		16.00%	14.00%	17.00%	5.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Telehealth | Point in Time
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		4.00%	3.00%	3.00%	1.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Telehealth | Over Time
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		13.00%	11.00%	13.00%	4.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Consumer services
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		80.00%	81.00%	80.00%	81.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Consumer services | Point in Time
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		69.00%	72.00%	70.00%	75.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Consumer services | Over Time
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		11.00%	8.00%	10.00%	6.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Research Services
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		20.00%	19.00%	20.00%	19.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Research Services | Point in Time
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		0.00%	0.00%	0.00%	0.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Research Services | Over Time
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		20.00%	19.00%	20.00%	19.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Service
Disaggregation Of Revenue [Line Items]
Percentage of Revenue	[1]	100.00%	100.00%	100.00%	100.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Service | Point in Time
Disaggregation Of Revenue [Line Items]
Percentage of Revenue	[1]	69.00%	72.00%	70.00%	75.00%
Product Concentration Risk [Member] | Revenue Benchmark [Member] | Service | Over Time
Disaggregation Of Revenue [Line Items]
Percentage of Revenue	[1]	31.00%	28.00%	30.00%	25.00%

[1] There was no Therapeutics revenue for the three and nine months ended December 31, 2022 and 2021.